$55B AbbVie Deal Collapse Boosts Anti-Inversion Campaign
The Obama administration's efforts to curb tax-motivated mergers and acquisitions claimed a huge victory Thursday when U.S. drugmaker AbbVie Inc. backpedaled on a planned $55 billion merger, a move that exposes...To view the full article, register now.
Already a subscriber? Click here to view full article